Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2011
08/16/2011US7998709 Process of producing a starch hydrolysate
08/16/2011US7998707 Quantitative measurement of gene expression from fixed paraffin embedded tissue
08/16/2011US7998706 Pyrimidine nucleobases
08/16/2011US7998704 Methods for magnetic resonance imaging
08/16/2011US7998703 Glyphosate-N-acetyltransferase (GAT) genes
08/16/2011US7998702 Mutant arabinose promoter for inducible gene expression
08/16/2011US7998686 Method for determining sepsis using pro-BNP
08/16/2011US7998680 Determining genotype of a polymorphic site in the hereditary hemochromatosis gene
08/16/2011US7998678 Methods for the detection of lung cancer
08/16/2011US7998674 Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas
08/16/2011US7998671 Methods of detecting prostate cancer using BAP28-related biallelic markers
08/16/2011US7998670 Method and probe set for detecting cancer
08/16/2011US7998491 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide
08/16/2011US7998490 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
08/16/2011US7998485 Sialoadhesin-related compositions and methods
08/16/2011US7998479 Substance specific to human PD-1
08/16/2011US7998473 Methods of treatment or prevention of gastrointestinal disorders using canine probiotic bifidobacterium
08/16/2011US7998472 CD34 stem cell-related methods and compositions
08/16/2011US7998469 Modified interferon beta for use in treatment and prevention of autoimmune, nervous system, cell proliferative, liver, blood and infcetious disorders; directed protein design
08/16/2011US7998468 Cytokine zalpha11 ligand antibodies
08/16/2011US7998413 Inexpensive disposable product; fast measurement; using surface plasmon resonance
08/16/2011CA2724313C Defensin polynucleotides and methods of use
08/16/2011CA2702866C Seed plants characterized by delayed seed dispersal
08/16/2011CA2552790C Process for the purification of bacterially expressed proteins
08/16/2011CA2512444C Screening method of agents for improving the memory and learning
08/16/2011CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof
08/16/2011CA2487095C Elongase genes and uses thereof
08/16/2011CA2458610C Non-linear amplitude dielectrophoresis waveform for cell fusion
08/16/2011CA2456648C Human antibodies specific for interleukin 15 (il-15)
08/16/2011CA2451608C Process for constructing a mutant utilizing the igh 3' enhancer
08/16/2011CA2451528C Novel aminopeptidase derived from bacillus licheniformis, gene encoding the aminopeptidase, expression vector containing the gene, transformant and method for preparation thereof
08/16/2011CA2412730C Method for preparing a physiologically active il-18 polypeptide
08/16/2011CA2405450C Dermacentor variabilis gaba-gated chloride channels
08/16/2011CA2397590C Antisense inhibition of ptp1b expression
08/16/2011CA2384917C Nucleic acid primers and probes for detecting tumor cells
08/16/2011CA2354325C Growth factor homolog zvegf3
08/16/2011CA2341776C Method for non-homologous transformation of yarrowia lipolytica
08/16/2011CA2321837C Systemic delivery of serum stable plasmid lipid particles for cancer therapy
08/16/2011CA2234477C Dna sequences coding for a cinnamoyl coa reductase, and applications thereof in the control of lignin contents in plants
08/16/2011CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same
08/12/2011CA2749440A1 Plant transformation using dna minicircles
08/11/2011WO2011097643A1 Selective reduction of allelic variants
08/11/2011WO2011097641A1 Methods and compositions useful in treatment of diseases or conditions related to repeat expansion
08/11/2011WO2011097603A1 Common light chain mouse
08/11/2011WO2011097582A2 Treatment of arachidonate 12-lipoxygenase, 12r type (alox12b) related diseases by inhibition of natural antisense transcript to alox12b
08/11/2011WO2011097509A2 Hypoxia-related gene signatures for cancer classification
08/11/2011WO2011097456A2 Compositions and methods for enhanced parvovirus transduction
08/11/2011WO2011097447A2 Production of recombinant virus
08/11/2011WO2011097407A1 Dosing regimens for treating and preventing ocular disorders using c-raf antisense
08/11/2011WO2011097388A1 Selective inhibition of polyglutamine protein expression
08/11/2011WO2011097381A2 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
08/11/2011WO2011097261A1 Stress-induced lipid trigger
08/11/2011WO2011097215A2 Plants with altered root architecture, related constructs and methods involving genes encoding lectin protein kinase (lpk) polypeptides and homologs thereof
08/11/2011WO2011097181A2 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
08/11/2011WO2011096926A1 Methods for preparing sequencing libraries
08/11/2011WO2011096782A2 Liquid flow apparatus, fixed quantity liquid supply apparatus, and target substance extracting apparatus and target substance extracting method using the two apparatuses
08/11/2011WO2011096756A2 Pharmaceutical composition for inhibiting abnormal proliferation of cells
08/11/2011WO2011096750A9 Method for preparing recombinant glycoproteins with high sialic acid content
08/11/2011WO2011096750A2 Method for preparing recombinant glycoproteins with high sialic acid content
08/11/2011WO2011096728A2 Method for proliferating stem cells by activating c-met/hgf signaling and notch signaling
08/11/2011WO2011096609A1 Athg1 protein having senescence delaying function and stress resisting function of plant, and gene and use of the protein
08/11/2011WO2011096573A1 Method for detection of ulcerative colitis
08/11/2011WO2011096555A1 Manufacturing method for l-amino acid
08/11/2011WO2011096554A1 MANUFACTURING METHOD FOR MUTANT rpsA GENE AND L-AMINO ACID
08/11/2011WO2011096534A1 Pharmaceutical composition for treatment and/or prevention of cancer
08/11/2011WO2011096519A1 Medicinal composition for treating and/or preventing cancer
08/11/2011WO2011096501A1 Photosensitizing fluorescent protein
08/11/2011WO2011096482A1 Method for reconstructing immune system using pluripotent stem cells
08/11/2011WO2011096481A1 Glycerol-3-phosphate acyltransferase homologue and use thereof
08/11/2011WO2011096302A1 Antibody specific to drug-resistant influenza virus and use of same
08/11/2011WO2011096223A1 Induced hepatic stem cell and process for production thereof, and applications of the cell
08/11/2011WO2011096211A1 Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
08/11/2011WO2011096210A1 Prmt1 and prmt6 for target genes of cancer therapy and diagnosis
08/11/2011WO2011096196A1 Lsd1 for target genes of cancer therapy and diagnosis
08/11/2011WO2011095958A2 Improvement of the grain filling of a plant through the modulation of nadh-glutamate synthase activity
08/11/2011WO2011095528A1 A method for increasing photosynthetic carbon fixation using glycolate dehydrogenase multi-subunit fusion protein
08/11/2011WO2011095495A1 Compositions and methods for inhibiting expression of ikk2 genes
08/11/2011WO2011095460A1 Soybean transformation using hppd inhibitors as selection agents
08/11/2011WO2011095374A2 Process for preparing filamentous fungal strains having a sexual cycle and a process for preparing sexually crossed filamentous fungal strains
08/11/2011WO2011095067A1 Methods and nucleotide fragments of predicting the ability of tumor invasion and metastasis in vitro
08/11/2011WO2011075677A3 Methods for producing polypeptides in protease-deficient mutants of trichoderma
08/11/2011WO2011075674A3 Identification of tumor suppressor genes in mutant non-human animals and a p53 mutant as a model for cancer
08/11/2011WO2011073925A3 C. histolyticum recombinant collagenases and method for the manufacture thereof
08/11/2011WO2011073326A3 Organic compositions to treat hsf1-related diseases
08/11/2011WO2011073214A3 A method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands
08/11/2011WO2011053144A3 Methods and compositions for dysferlin exon-skipping
08/11/2011WO2011048046A3 Synthetic phytase variants
08/11/2011WO2011046757A9 Accelerating thrombus resolution through augmentation of p53 activity
08/11/2011WO2011026906A3 Novel microorganism and its use in lignocellulose detoxification
08/11/2011WO2011022606A3 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
08/11/2011WO2011005867A8 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
08/11/2011WO2011005861A9 Oligonucleotide end caps
08/11/2011WO2010141390A3 Nucleotide transient binding for sequencing methods
08/11/2011WO2010048352A8 Methods for treating eye disorders
08/11/2011US20110197316 Methods and compositions for transgenic plants with enhanced abiotic stress resistance and biomass production
08/11/2011US20110197315 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield
08/11/2011US20110197314 Methods and Compositions for Controlling Plant Pests
08/11/2011US20110197313 Pepper Hybrid E42.2346
08/11/2011US20110197312 Indigenous Viral Satellite RNA Associate with Cucumber Mosaic Virus used as a Biological Control Agent against Tomato Diseases caused by Virus Strains, Viroids, and Fungi
08/11/2011US20110197311 Use of multiple transformation enhancer sequences to improve plant transformation efficiency